EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

A prospective, comparative, double arm, quasi-experimental study to evaluate the safety and efficacy of short contact 4% hydroquinone versus Q-switched Nd: YAG laser in acne-induced post-inflammatory hyperpigmentation in skin of color

Ananya B. Reddy, Vishal Bejai, Malcolm Pinto, Manjunath Mala Shenoy, Spandana P. Hegde, Amina Asfiya

Pigment International · 2026

DOI: 10.4103/pigmentinternational_35_24 ↗
AstrattDettalji biblijografiċi

Astratt

Background: Post-inflammatory hyperpigmentation (PIH) is a common complication of acne, particularly in the ethnic skin. A wide variety of therapies are used, as no simple best-effective treatments are available. Hydroquinone (HQ) remains the mainstay of PIH care. Lasers and light sources may be an effective addition to therapy or an alternative to treatment failure. Aims: To evaluate the safety and efficacy of short contact, topical 4% HQ versus quality-switched Nd: YAG (QS Nd:YAG) laser in acne-induced PIH in patients with skin of color. Methods: Sixty two patients with acne-induced PIH were randomly divided into two groups. A detailed socio-demographic and clinical history was elicited. Thirty one patients received topical 4% HQ daily at night for 30 minutes for 3 months and 31 patients underwent QS Nd:YAG laser every month for 3 months as treatment. Patient satisfaction score, observer score, and postacne inflammatory hyperpigmentation index (PAHPI) were recorded at base line, first, second, and third month. Results: A significant reduction in PAHPI score in both groups of 4% HQ and QS Nd:YAG laser was noted. A higher patient satisfaction score was noted among the patients who underwent treatment with QS Nd:YAG laser compared to 4% HQ which was statistically not significant. Conclusion: This study shows that both short contact 4% HQ and low fluence QS Nd:YAG laser have significant therapeutic effect on acne-induced PIH. With higher patient satisfaction scores, QS Nd: YAG laser is a good alternative in patients not compliant with topical therapy.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →